Scopolamine (hydrobromide trihydrate)

CAT:
804-HY-W010892-01
Size:
5 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Scopolamine (hydrobromide trihydrate) - image 1

Scopolamine (hydrobromide trihydrate)

  • UNSPSC Description:

    Scopolamine hydrobromide trihydrate (Hyoscine hydrobromide trihydrate) is used in ophthalmic preparations and has the potential for transdermal patches of motion sickness[1].
  • Target Antigen:

    mAChR
  • Type:

    Natural Products
  • Related Pathways:

    GPCR/G Protein;Neuronal Signaling
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Neurological Disease
  • Assay Protocol:

    https://www.medchemexpress.com/scopolamine-hydrobromide-trihydrate.html
  • Purity:

    99.89
  • Solubility:

    DMSO : 125 mg/mL (ultrasonic)
  • Smiles:

    O=C([C@@H](C1=CC=CC=C1)CO)O[C@H]2C[C@H]3[C@@H]4O[C@@H]4[C@H](N3C)C2.[H]Br.[H]O[H].[H]O[H].[H]O[H]
  • Molecular Weight:

    438.31
  • References & Citations:

    [1]National Toxicology Program. , et al. NTP Toxicology and Carcinogenesis Studies of Scopolamine Hydrobromide Trihydrate (CAS No. 6533-68-2) in F344 Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser. 1997 Mar;445:1-277.Eur J Pharmacol. 2024 Aug 16:176903.|bioRxiv. 2023 Jul 6.|Eur J Med Chem. 2024 Dec 5.|Eur J Med Chem. 2023 Dec 21, 116071.|Food Chem. 30 November 2022, 133593.|J Neurosci. 2023 Jun 8;JN-RM-0128-23.|Neuropharmacology. 2022 Jul 11;109191.|Neurosci Lett. 2021 Sep 1;136209.|Phytomedicine. 2024 Jun 4:131:155802.|Phytomedicine. 2024 Mar 11, 155531.|Phytomedicine. 2024 Oct 31:135:156209.|Theranostics. 2024 Sep 3;14(14):5551-5570.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, sealed storage, away from moisture)
  • Clinical Information:

    Launched
  • CAS Number:

    6533-68-2